UBE2I Recombinant Antibody, PerCP-Cy5.5 Conjugated
Product Specifications
Background
Accepts the ubiquitin-like proteins SUMO1, SUMO2, SUMO3, SUMO4 and SUMO1P1/SUMO5 from the UBLE1A-UBLE1B E1 complex and catalyzes their covalent attachment to other proteins with the help of an E3 ligase such as RANBP2, CBX4 and ZNF451. Can catalyze the formation of poly-SUMO chains. Necessary for sumoylation of FOXL2 and KAT5. Essential for nuclear architecture and chromosome segregation. Sumoylates p53/TP53 at 'Lys-386'. Mediates sumoylation of ERCC6 which is essential for its transcription-coupled nucleotide excision repair activity.
Synonyms
C358B7.1; P18; UBC9; UBE2I; SUMO1 protein ligase.
Gene ID
7329
Swiss Prot
P63279
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse
Target
UBE2I
Clonality
Recombinant
Isotype
IgG
Conjugation
PerCP-Cy5.5
Source
KLH conjugated synthetic peptide derived from human UBE2I
Applications
WB, IF, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
482nm/694nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF (), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
7329
Predicted Cross Reactivity
Rat
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
043759-ML405 100 µL
VIPR2, NT (VIPR2, VIP2R, Vasoactive intestinal polypeptide receptor 2, Helodermin-preferring VIP receptor, Pituitary adenylate cyclase-activating polypeptide type III receptor, VPAC2) (MaxLight 405) discontinued
Ask
View Details 